Identificação
Identificação pessoal
- Nome completo
- Cristina Maria da Costa Peixoto Lisboa
Identificadores de autor
- Ciência ID
- 721B-A48E-DA1B
- ORCID iD
- 0000-0002-0995-6637
Endereços de correio eletrónico
- peixoto@ibet.pt (Profissional)
Formação
Grau | Classificação | |
---|---|---|
2009/02/09
Concluído
|
Ciências da Engenharia e Tecnologia (Doutoramento)
Especialização em Biotechnology
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
|
1993/09/30
Concluído
|
Química Aplicada (Licenciatura)
Especialização em Biotechnology
FCT-UNL, Portugal
|
Percurso profissional
Ciência
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2015 - Atual | Investigador (Investigação) | iNOVA4Health, Portugal |
iNOVA4Health, Portugal | ||
1993 - 1995 | Estagiário de Investigação (Investigação) | Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal |
Outros
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2021/01/01 - Atual | Coordinator of Bioproduction Unit | Instituto de Biologia Experimental e Tecnológica, Portugal |
Instituto de Biologia Experimental e Tecnológica, Portugal | ||
2009/03/01 - Atual | Head of DSP Development Lab, Animal Cell technology Unit | Instituto de Biologia Experimental e Tecnológica, Portugal |
1996/01/01 - 2008/02/28 | Researcher at IBET | Instituto de Biologia Experimental e Tecnológica, Portugal |
Projetos
Bolsa
Designação | Financiadores | |
---|---|---|
2021 - Atual | AAV PRocess INTensification with 3D printed materials
EXPL/EQU-EQU/1567/2021
Investigador
|
Em curso
|
2020/10 - Atual | ADDovenom: Novel Snakebite Therapy Platform ofUnparalleled Efficacy, Safety and Affordability, 899670
899670
Investigador
|
European Commission Third Framework Programme
Em curso
|
2020 - Atual | TRANSVAC-DS, Design Study for a European Vaccine, Infrastructure
951668
Investigador
|
Concluído
|
2019 - 2023 | CRUZIVAX
815418
Investigador
|
Concluído
|
Projeto
Designação | Financiadores | |
---|---|---|
2021 - Atual | Downstream Process Development of AAVs, Sartorius, Contract research services
SART2021
Investigador responsável
|
Em curso
|
2020/05 - Atual | Downstream Process Development of a new GT target, CSL Behring, Research contract service
CSL2BE
Investigador responsável
Instituto de Biologia Experimental e Tecnológica, Portugal
|
|
2023/01/01 - 2025/12/31 | Acelerar a fabricação de vesículas extracelulares derivadas de células estaminais pluripotentes humanas para regeneração cardíaca
2022.10467.PTDC
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Fundação para a Ciência e a Tecnologia
Em curso
|
2021/01/01 - 2025/12/31 | Life Sciences for a Healthy and Sustainable Future
LA/P/0087/2020
Universidade Nova de Lisboa Microbiologia Molecular Estrutural e Celular, Portugal
Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal Fundação Calouste Gulbenkian, Portugal Instituto Gulbenkian de Ciência, Portugal Instituto de Biologia Experimental e Tecnológica, Portugal BioResources 4 Sustainability, Portugal Universidade NOVA de Lisboa, Portugal iNOVA4Health, Portugal |
Fundação para a Ciência e a Tecnologia
Em curso
|
2022 - 2023 | Characterization of viral vectors, Vector Biopharma
VBHPLC
Investigador responsável
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Concluído
|
2022 - 2023 | Bioprocess development of viral vector, University of Munique
TUM2022
Investigador responsável
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Concluído
|
2021 - 2022 | Production of rec Proteins, Pharmis
Ph2021
Investigador responsável
|
Concluído
|
2021 - 2021 | Production of viral vector, Repligen
REP2021
Investigador
|
Concluído
|
2018 - 2021 | Accelerating lentivirus manufacturing: an enginnering driven approach
PTDC/EQU-EPQ/29306/2017
PTDC/EQU-EPQ/29306/2017
Investigador responsável
Instituto de Biologia Experimental e Tecnológica, Portugal
|
N/A |
2017/05/01 - 2020/12/31 | New structured substrates for downstream processing of complex biopharmaceuticals
M-ERA-NET2/0015/2016
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2019/01/01 - 2019/12/31 | iNOVA4Health - Programa de Medicina Translacional iBET, CEDOC/FCM, IPOLFG e ITQB
UID/Multi/04462/2019
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2019 - 2019 | Process Development for Turnstone Biologics
TBIO2019
Investigador
|
Concluído
|
2017 - 2019 | Viral vectors Bioprocess, GELifesciences, Contract research service
GE2018
Investigador responsável
|
Concluído
|
2014/05/01 - 2017/04/30 | Identificação de novos bioterapêuticos e desenvolvimento de sistemas de expressão
ERA-IB-2/0007/2013
Instituto de Biologia Experimental e Tecnológica, Portugal
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica António Xavier, Portugal |
Fundação para a Ciência e a Tecnologia
Concluído
|
2016 - 2017 | Bioprocess development of OV - Tilt, Contract research service
TILT 2016
Investigador responsável
|
|
2016 - 2017 | DSP development for OV - VCN, Contract research service
VCN2016
Investigador responsável
|
Concluído
|
2013 - 2017 | Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic
drift in seasonal influenza virus exposure
info:eu-repo/grantAgreement/EC/FP7/602640/EU
Investigador
|
Concluído
|
2014 - 2016 | Enveloped VLP production & purification, Merck Millipore, Contract research service
Merck2014
Investigador responsável
|
Concluído
|
2012 - 2016 | Viral Capture and Purification System: Smart macroporous structures for the affinity purification of retroviral particles
Investigador
|
|
2015 - 2015 | Standard virus - Purification, Bioreliance, Contract research service
BIOREL2015
Investigador responsável
|
Concluído
|
2013 - 2015 | Combining siRNA and AAV therapy approaches to target human basal-like breast cancer: from vector development to anti-tumor
efficacy evaluation.
Investigador
|
Concluído
|
2012/03/01 - 2015 | Probing adenovirus-host cell interactions: a systems biotechnology approach to improve production of gene delivery vectors
Investigador
|
Universidade do Algarve Faculdade de Ciências e Tecnologia |
2012 - 2015 | Enhanced membrane technology project - Sartorius Stedim, Contract research service
Sartorius2012
Investigador responsável
|
|
2013/07/01 - 2014/09/30 | Aceleração da purificação de biofármacos complexos através de novos processos cromatográficos, técnicas analíticas avançadas
e ferramentas computacionais de desenho processual
EXPL/BBB-EBB/0790/2012
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2013/07/01 - 2014 | Development of a scalable strategy for stem cells purification
Investigador responsável
|
Concluído
|
2010 - 2014 | Retroviral like particles: improving potential as candidate vaccines for Hepatitis C
Investigador
Instituto de Biologia Experimental e Tecnológica, Portugal
|
|
2013 - 2013 | DSP development for gene therapy vectors - Pall Lifescience, Research contract project
Pall 2013
Investigador responsável
|
|
2012 - 2013 | Debottlenecking the purification of complex biopharmaceuticals with new chromatographic processes, advanced analytics, and
computer-aided process design tools
Investigador
|
|
2011 - 2013 | Recombinant protein production and purification, BayerSchering Pharma AG, Contract research service
Bayer2011/2013
Investigador
|
Concluído
|
2010 - 2013 | hCE-2 - expression and characterization in in vitro and in silico models
Investigador
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Concluído
|
2010 - 2013 | 2D fluorometry: a powerful tool to improve mammalian cell process development
PTDC/EBB-BIO/111530/2009
Investigador
|
Concluído
|
2011/01/01 - 2012/12/31 | Strategic Project - LA 4 - 2011-2012
PEst-OE/EQB/LA0004/2011
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica António Xavier, Portugal
Fundação Calouste Gulbenkian, Portugal Instituto de Biologia Experimental e Tecnológica, Portugal Universidade NOVA de Lisboa NOVA Medical School, Portugal |
Fundação para a Ciência e a Tecnologia
Concluído
|
2011 - 2012 | Theraptech Project - Alloksys Life Science BV
Theraptech2011
Investigador responsável
|
Concluído
|
2011 - 2012 | Viral vectors for gene therapy (MGVS), Contract research service
MGVS2011
Investigador responsável
|
Concluído
|
2008 - 2011 | Non-human adenovirus vectors for gene teraphy transfer to brain - BRAINCAV
FP7
Investigador
Instituto de Biologia Experimental e Tecnológica, Portugal
|
|
2007/10/01 - 2010/09/30 | Purificação de vírus com envelope: racionalização e aplicação de fundamentos teóricos visando a integração de processos
PTDC/EQU-EQU/71645/2006
Instituto de Biologia Experimental e Tecnológica, Portugal
Universidade NOVA de Lisboa Faculdade de Ciências e Tecnologia, Portugal Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica António Xavier, Portugal |
Fundação para a Ciência e a Tecnologia
Concluído
|
2007 - 2010 | Manufacturing Canine Adenovirus Vectors for Gene Therapy: development of MDCK CAV-2 E1-complementing cell lines.
Investigador
|
|
2006 - 2009 | BACULOGENE - Baculovirus Vectors for Gene Therapy
EU (FP6 - 2007)
Desenvolvimento técnico
Instituto de Biologia Experimental e Tecnológica, Portugal
|
|
2005/05/01 - 2008/06/30 | THERAVECT - Production, purification and storage of retroviral vectors produced by modular master producer cells: focus on
CoIVII vectors for the Epidermolysis Bullosa therapy
POCI/V.5/A0003/2005
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluído
|
2004 - 2006 | Integrated strategy for the production, Purification and storage of Adenovírus
POCTI/BIO/46515/2002
Desenvolvimento técnico
Instituto de Biologia Experimental e Tecnológica, Portugal
|
Concluído
|
2003 - 2005 | Novel strategies for a safe Rotavirus vaccine
EU (QLRT-2001-01249).
Investigador
|
Concluído
|
2001 - 2004 | Mass production of Cowdria ruminantium for a cost effective veterinary vaccine aaginst heartwater
EC 8 ACP TPS 040
Investigador
|
Concluído
|
Outro
Designação | Financiadores | |
---|---|---|
2021/01/01 - 2022/12/30 | Improvement of chromatographic separation for AAVs and recProteins, Bio-Rad Contract research service
BR2021
Investigador responsável
|
Concluído
|
Produções
Publicações
Artigo em revista |
|
Capítulo de livro |
|
Atividades
Apresentação oral de trabalho
Título da apresentação | Nome do evento Anfitrião (Local do evento) |
|
---|---|---|
2024/10 | (R)Evolution in Downstream Processing of New Modalities: What Will be the Role of Chromatography? | SPICA International Symposium on Preparative and Industrial Chromatography and Allied Techniques
(Milan, Itália)
|
2023/01 | Challenges and Trends in Lentivirus Manufacturing | Sartorius Internal webinar
Sartorius
|
2022/10/14 | Progress and Trends of Virus Based Biopharmaceuticals Purification | SPICA International Symposium on Preparative and Industrial Chromatography and Allied Techniques |
2022 | Strategies and Advances in Purification of New Therapeutic Modalities | Bioprocess Summit 2022
(Barcelona)
|
2021/10/20 | Advances in Purification of Emerging Therapeutic Modalities | SPICA International Symposium on Preparative and Industrial Chromatography and Allied Techniques |
2021/05/03 | Exploring new strategies to improve viral vectors purification processes | Art of Gene Therapy - Merck |
2020/07 | Advance Purification of Biotherapeutic particles: Exploiting new materials and operation modes | Bioprocess Summit 2020 |
2019 | Improving downstream process of influenza virus-like particles using a pseudo-affinity strategy | Bioprocess Summit 2019
(Lisbon, Portugal)
|
2018 | Improving oncolytic adenovirus manufacturing: designing GMP compatible bioprocesses | ISPPP
(Berlin, Alemanha)
|
2018 | Improving downstream process of influenza virus-like particles using a pseudo-affinity strategy | Bioprocess Summit
(Boston, Estados Unidos)
|
2018 | Leveraging vectored vaccine candidates manufacturing to GMP compatible bioprocess | Vaccine Technology VI
(Mont Tremblant, Canadá)
|
2018 | Improving Influenza VLP vaccine purification: the effect of novel analytical tools | ESBES
(Lisbon, Portugal)
|
2018 | Challenges in Purifying Influenza Virus-Like Particles | Bioprocess Summit
(Lisbon, Portugal)
|
2017 | Improving purification of influenza virus-like particles using a pseudo-affinity strategy | Affinity
(Paris, França)
|
2017 | Facing the challenges of downstream process of new biopharmaceuticals | MicroBiotec
(Porto, Portugal)
|
2017 | Improving downstream process of new biopharmaceuticals using non - traditional chromatographic strategies | Anything but Conventional Chromatography
(Lisbon, Portugal)
|
2016 | Overcome DSP challenges | UPS&DSP Technology Forum Sartorius
(Gottingen, Alemanha)
|
2016 | Improving and Monitoring Influenza VLPs Downstream Process using a click chemistry approach | ISBioTech 5th Spring Meeting
(Washington DC, Estados Unidos)
|
2016 | Purification of Stem Cells | • SPICA 16th International Symposium on Preparative and Industrial Chromatography and Allied Techniques
(Vienna, Áustria)
|
2016 | Quality control of viral vectors, trends and overview | • Universitat Autònoma de Barcelona, Centre de Biotecnologia Animal i Teràpia Gènica (CBATEG)
(Barcelona, Espanha)
|
2015 | Universal label-free in-process analytical tool for Influenza VLPs quantification | Affinity
(Puerto Vallarta, México)
|
2015 | Quality control of viral vectors-overview of characterization methods | Workshop EMBO
(Evry, França)
|
2014 | Vaccines and Virus Purification | Merck Millipore workshop
(Boston, Estados Unidos)
|
2013 | New insights in virus purification using enhanced membrane technology | Downstream Technology Forum - Sartorius
(Gottingen, Alemanha)
|
2012 | Facing the challenges of downstream process of virus | Bioproduction
(Berlin, Alemanha)
|
2012 | Downstream Process of virus: Overcoming bottlenecks | MSSS2012
(Portoroz, Eslovénia)
|
2009 | Towards purification of baculovirus vectors using membrane technology | Bioprocess International Conference
(Dusseldorf, Alemanha)
|
2008 | Downstream Process of Complex Biopharmaceuticlas at IBET | AKTA User day - GELifesciences
(Oeiras, Portugal)
|
2008 | Towards purification of gene therapy vectors using membrane technology | 4th European Downstream Technology Forum
(Gottingen, Alemanha)
|
Orientação
Título / Tema Papel desempenhado |
Curso (Tipo) Instituição / Organização |
|
---|---|---|
2024/01/01 - Atual | Improving lentiviral vector bioprocessing using an engineering approach
Orientador de Cláudia Paiva
|
|
2021 - 2025/02/14 | An engineering driven approach for purification of enveloped virus-based biotherapeutics
Orientador de Rita Patricio Fernandes
|
|
2024 - 2024 | Implementation of Raman PAT Technology in tangential flow filtration to enhance downstream processing in gene therapy
Orientador
|
Master Chemical Engineering (Mestrado) |
2023 - 2024 | Novel Affinity-Based Technologies for Targeting Distinct Bio-logical Systems
Orientador
|
Master Biotechnology |
2022/09/01 - 2023/11/27 | Accelerating complex biopharmaceuticals manufacturing
Orientador de Afonso Ruiz
|
Master Biotechnology (Mestrado) |
2022 - 2022 | Accelerating Virus-Based Biopharmaceuticals Manufacturing
Orientador
|
Master (Mestrado) |
2022 - 2022 | Establishment of an insect cell-based platform for production of adenovirus-like particles (ADDomer particles) as a snakebite
therapy
Coorientador
|
|
2018 - 2022 | Integrated continuous manufacturing of adeno-associated virus (AAVs)
Orientador de João Mendes
|
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2018 - 2022 | Accelerating Lentivirus manufacturing: an engineering driven approach
Orientador de Ana Sofia Moreira
|
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2020/09/01 - 2021/11/30 | Get moving enveloped virus manufacturing to the clinic
Orientador de Mariana Cordeiro de Oliveira Vinagre
|
|
2020/06/01 - 2021/01/06 | Debottlenecking lentivirus manufacturing
Orientador de David Guia Cavaco
|
|
2018 - 2019 | Developing and Improving Purification Strategies for New Biopharmaceuticals
Orientador de Rita Fernandes
|
|
2016 - 2019 | Advancing purification of viral targets
Orientador de Mafalda Moleirinho
|
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2014 - 2018 | Downstream strategies for VLPs as candidate universal vaccine for Influenza
Coorientador de Sofia B. Carvalho
|
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2014 - 2018 | Development of integrated strategies for the downstream processing of human stem cells for clinical application
Coorientador de Barbara Cunha
|
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2014 - 2015 | Advances in DSP of enveloped VLPs
Orientador de Mafalda Moleirinho
|
|
2010 - 2014 | Improving Downstream processing for viral vectors and viral vaccines
Coorientador
|
|
2011 - 2011 | Development of virus downstream process for gene therapy
Orientador de Patricia Roch
|
|
2011 - 2011 | Purification of Complex Biopharmaceuticals with New Chromatographic Processes, Advanced Analytics, and Computer-Aided Process
Design Tools
Orientador de Duarte Martins
|
|
2007 - 2010 | Downstream Processing Development of Enveloped Viruses for Clinical Applications: InnovativeTools for Rational Process Optimization
Coorientador
|
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
2003 - 2008 | Purification of Retroviral Vectors for Gene Therapy
Coorientador
|
Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal
|
Participação em evento
Descrição da atividade Tipo de evento |
Nome do evento Instituição / Organização |
|
---|---|---|
2023/11/17 - 2023/11/19 | Session Chair - 24th Planova Workshop, Florence
Oficina (workshop)
|
24th Planova™ Workshop Florence |
2022/10 - 2022/10 | Session Chair - Continuous manufacturing of emerging therapeutic modalities, Integrated Continuous Biomanufacturing V, ECI
Conference
Conferência
|
Integrated Continuous Biomanufacturing V |
Júri de grau académico
Tema Tipo de participação |
Nome do candidato (Tipo de grau) Instituição / Organização |
|
---|---|---|
2021/01/24 | Bioprocess improvement for manufacturing of recombinant adeno-associated virus-based gene delivery vectors
Arguente principal
|
Pranavkumar Rajendraprasad JOSHI (Doutoramento)
McGill University, Canadá
|
2021/01/13 | Artificial scaffolds for affinity-triggered bioseparations
Arguente
|
Manuel Matos (Doutoramento)
FCT-UNL, Portugal
|
2020/04/06 | Development of a novel purification platform for Fab antibody fragments based on affinity peptides and multimodal ligands
Arguente principal
|
André Nascimento (Doutoramento)
Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento, Portugal
|
2020 | Single-Column Chromatography with Recycle Lag Analog to Simulated Moving Bed Processes
Arguente
|
Abimaelle Silva Chibério (Doutoramento)
FCT-UNL, Portugal
|
2015 | Implementation of a Technology Transfer System
Arguente principal
|
Ana Isabel Alves (Mestrado)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2013 | Analysis and Optimization of the Limiting Cases of Simulated Countercurrent Adsorption:TrueMoving Bed and Single-Column Analog
Processes
Arguente
|
Ricardo Silva (Doutoramento)
FCT-UNL, Portugal
|
2013 | Functional monolithic platforms for antibody purification
Arguente principal
|
Telma Godinho Barroso Maciel Fernandes (Doutoramento)
FCT-UNL, Portugal
|
Curso / Disciplina lecionado
Disciplina | Curso (Tipo) | Instituição / Organização | |
---|---|---|---|
2016 - Atual | Downstream Processing of Viral Vectors. Cell Culture-based Viral Vaccines - ESACT Course, Llafranc, Spain. | ||
2010 - Atual | Purification of biopharmaceuticals | Ciências de Engenharia Química e Bioquímica (Licenciatura) | FCT-UNL, Portugal |
2014 - 2018 | Purification and quality control of gene therapy vectors | (Doutoramento) | |
2010 - 2015 | Downstream Process of Biopharmaceuticals | (Doutoramento) | Universidade Nova de Lisboa Instituto de Tecnologia Química e Biológica, Portugal |
2009 - 2011 | Animal Cell Technology: Biopharmaceuticals production | Tecnicos Farmacia |